Micro-X Highlights Rover Orders And Medical CT Focus In Results Presentation
MX1: $0.032 +0.00% · MC: $23M
Micro-X’s results presentation reiterates its strategic focus on medical CT and reports ten Rover orders during the September quarter, followed by seven more after quarter-end. The earlier quarterly update said quarterly product sales receipts rose from $0.2 million to $1.2 million, while the company also reported a threefold expansion in its Rover sales pipeline.

Comments